China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
28.71
-0.07 (-0.24%)
Mar 26, 2026, 3:00 PM CST

SHA:600511 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
21,71521,69225,81921,59421,05123,789
Market Cap Growth
-4.13%-15.98%19.57%2.58%-11.51%-36.06%
Enterprise Value
12,51316,50520,03415,88916,87119,902
Last Close Price
28.7828.7533.3027.1425.9128.55
PE Ratio
10.8810.8612.9110.0610.7213.56
Forward PE
10.3510.2510.718.9110.0112.87
PS Ratio
0.410.410.510.440.460.51
PB Ratio
1.071.071.361.231.331.66
P/TBV Ratio
1.201.201.551.411.531.93
P/FCF Ratio
11.2111.2016.898.379.2912.77
P/OCF Ratio
10.8310.8215.567.928.7912.15
PEG Ratio
5.182.372.372.372.372.37
EV/Sales Ratio
0.240.320.400.320.370.43
EV/EBITDA Ratio
5.667.509.056.396.969.24
EV/EBIT Ratio
6.047.969.526.707.289.69
EV/FCF Ratio
6.468.5213.116.167.4510.69
Debt / Equity Ratio
0.030.030.050.030.030.05
Debt / EBITDA Ratio
0.230.230.360.210.210.31
Debt / FCF Ratio
0.270.270.550.210.230.38
Net Debt / Equity Ratio
-0.54-0.54-0.53-0.59-0.53-0.46
Net Debt / EBITDA Ratio
-4.98-4.98-4.53-4.18-3.46-3.07
Net Debt / FCF Ratio
-5.66-5.66-6.57-4.02-3.70-3.55
Asset Turnover
1.471.471.501.601.581.76
Inventory Turnover
9.669.6610.5411.9011.5313.05
Quick Ratio
1.731.731.681.731.711.63
Current Ratio
2.082.082.042.042.021.93
Return on Equity (ROE)
10.64%10.64%11.67%13.98%14.09%14.05%
Return on Assets (ROA)
3.62%3.62%3.90%4.78%5.03%4.85%
Return on Invested Capital (ROIC)
15.00%18.22%21.00%25.82%24.13%21.03%
Return on Capital Employed (ROCE)
9.70%9.70%10.50%12.80%13.70%13.50%
Earnings Yield
9.19%9.20%7.75%9.94%9.33%7.37%
FCF Yield
8.92%8.93%5.92%11.96%10.76%7.83%
Dividend Yield
2.78%-2.40%3.15%3.02%2.45%
Payout Ratio
31.34%31.34%34.12%33.06%31.16%36.36%
Buyback Yield / Dilution
-0.00%-0.00%-0.00%0.00%0.00%-0.00%
Total Shareholder Return
2.79%-0.00%2.40%3.15%3.02%2.45%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.